GHK-Cu: Copper-Tripeptide, Dermal Regenerator & Senescence

What is GHK-Cu

GHK-Cu is a complex formed by:

• GHK: the tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys, MW ~340 Da in its free form).
• Cu²⁺: a copper ion coordinated by the central histidine and the amino terminal groups.

The GHK-Cu complex is the biologically active form. Without the copper, GHK alone has reduced activity — the metal-peptide coordination is what allows it to catalyze redox transfer and serve as a Cu²⁺ shuttle between plasma proteins.

Discovery & age-related decline

Dr. Loren Pickart isolated GHK from human plasma in 1973 while studying differences between young and older plasma. He observed that young plasma induced hepatic proliferation in cell cultures and traced the activity back to GHK.

Typical plasma levels (literature):

• 20–30 years: ~200 ng/mL
• 60+ years: ~80 ng/mL (≈60% decline)

This drop coincides with the deterioration of regenerative capacity in skin, mucosa, and connective tissue — one of the rationales for investigative therapeutic use.

Molecular mechanism

GHK-Cu operates at multiple levels simultaneously — it's not a single-receptor agonist:

Epigenetic regulation

Microarray analyses show that GHK-Cu modulates expression of a significant percentage of the human genome (literature figures: around 30%; Pickart, 2015). In models where the tripeptide is applied, genes associated with DNA repair, chronic inflammation and cellular senescence are downregulated; extracellular matrix genes (collagen, GAGs, decorin) are upregulated.

Collagen and extracellular matrix synthesis

Stimulates dermal fibroblasts to produce type I collagen, elastin, proteoglycans, and hyaluronic acid. Also modulates matrix metalloproteinases (MMPs) — key for tissue remodeling.

Antioxidant and anti-inflammatory

The copper center participates in redox reactions that neutralize hydroxyl radicals, and reduces pro-inflammatory cytokines (TNF-α, IL-6) in cultured keratinocytes.

Angiogenesis and wound healing

Promotes capillary formation (VEGF, bFGF) — one of the rate-limiting steps in chronic wound closure.

Key studies

Wound healing

Murine models and human trials with diabetic ulcers and ischemic wounds show accelerated closure and better scar quality when topical GHK-Cu is applied vs. control.

Skin photoaging

Double-blind trials with GHK-Cu creams in post-menopausal women showed wrinkle reduction, better firmness, and dermal density measured by ultrasound at 12 weeks.

Hair growth

Inhibits 5-α-reductase in vitro (same target as finasteride but different mechanism) and extends the anagen phase of the hair follicle. Small studies suggest improved hair density with sustained topical application.

Cellular senescence

In cultured senescent fibroblasts, GHK-Cu partially reverses molecular markers of senescence. It's among the compounds with the strongest in vitro evidence of senomorphic activity (doesn't destroy zombie cells but reduces their SASP).

Routes of administration

GHK-Cu has been studied via three main routes:

• Topical — the most common. Reconstituted in bacteriostatic water + cream base (or direct application). Skin penetration is facilitated by the peptide-metal complex, which crosses the stratum corneum better than free GHK.
• Subcutaneous — for systemic-effect research in aging or deep injuries. Short plasma half-life (~30 min), hence frequent dosing.
• Microneedling / mesotherapy — combined with dermarollers (~0.5–1.0 mm) in skin revitalization protocols to enhance penetration.

Literature ranges: 1–2 mg per topical application, 100 µg–2 mg/day subcutaneous (varies by model and goal).

Reconstitution

Vial of 100 mg + 5 mL bacteriostatic water = 20 mg/mL.

For a 500 µg subcutaneous dose = 0.025 mL = 2.5 units on a U100 syringe.

For topical use: reconstitute and mix with cream base (1–2% final concentration) or apply directly to clean skin. Store at 2–8 °C after reconstitution, use within 4–6 weeks.

For custom calculations: Reconstitution calculator.

GHK-Cu in blends: GLOW & KLOW

GHK-Cu is the "structural regenerator" component in two catalog blends:

• GLOW: BPC-157 + GHK-Cu + TB-500 — tissue repair + extracellular matrix + remodeling. Indicated for skin, collagen, and general healing research.
• KLOW: GLOW + KPV — adds the anti-inflammatory component. Indicated when active inflammation is present (psoriasis, eczema, dermatitis).

Compared to GHK-Cu alone, the blends add:

• BPC-157: accelerated angiogenesis and deep soft-tissue repair.
• TB-500: cell motility and faster repair.
• KPV (KLOW only): NF-κB blockade for chronic inflammation.

If the focus is dermal aging monotherapy (wrinkles, photo-damage, density), GHK-Cu alone is enough. If there's a tissue-repair component (scars, injuries, post-procedure), GLOW. If there's inflammation, KLOW.

GHK-Cu at Renova

GHK-Cu 100 mg — lyophilized vial, $100 USD. Reconstitutes with bacteriostatic water (sold separately).